This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXMPEA7D094_M.jpg
The diabetes market size is projected to reach $2.8 billion by 2026. Therefore, it’s no surprise that companies that work on developing technology that treat diabetes are receiving attention from long-term investors.
In this article I analyze two diabetes companies, Senseonics Holdings Inc . (SENS) and Insulet Corp . (PODD), to see which of their stocks is currently a better buy.
